Report Detail

Request for Sample of this report

Pharma & Healthcare Global Biologics and Biosimilars Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4654110
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 140 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at US$ 454100 million in 2024 and is forecast to a readjusted size of USD 797670 million by 2031 with a CAGR of 8.5% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product"s patent expires. Reference to the innovator product is an integral component of the approval.
Global key biologics and biosimilars manufacturers include Johnson & Johnson, Pfizer, Roche, Amgen, AbbVie, and others. The top five manufacturers together account for approximately 50% of the market share, with the largest manufacturer being Pfizer with over 20% share. In terms of product categories, monoclonal antibodies are the largest segment with a market share of 43%, followed by vaccines with a 30% share. In terms of applications, hospitals are the top application area, with about 85% of the market share.
This report is a detailed and comprehensive analysis for global Biologics and Biosimilars market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biologics and Biosimilars market size and forecasts, in consumption value ($ Million), 2020-2031
Global Biologics and Biosimilars market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Biologics and Biosimilars market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Biologics and Biosimilars market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics and Biosimilars
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics and Biosimilars market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others
Market segment by Application
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologics and Biosimilars, with revenue, gross margin, and global market share of Biologics and Biosimilars from 2020 to 2025.
Chapter 3, the Biologics and Biosimilars competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Biologics and Biosimilars market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics and Biosimilars.
Chapter 13, to describe Biologics and Biosimilars research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biologics and Biosimilars by Type
    • 1.3.1 Overview: Global Biologics and Biosimilars Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Biologics and Biosimilars Consumption Value Market Share by Type in 2024
    • 1.3.3 Monoclonal Antibodies
    • 1.3.4 Interferon
    • 1.3.5 Insulin
    • 1.3.6 Vaccines
    • 1.3.7 Others
  • 1.4 Global Biologics and Biosimilars Market by Application
    • 1.4.1 Overview: Global Biologics and Biosimilars Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Biologics and Biosimilars Market Size & Forecast
  • 1.6 Global Biologics and Biosimilars Market Size and Forecast by Region
    • 1.6.1 Global Biologics and Biosimilars Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Biologics and Biosimilars Market Size by Region, (2020-2031)
    • 1.6.3 North America Biologics and Biosimilars Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Biologics and Biosimilars Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Biologics and Biosimilars Market Size and Prospect (2020-2031)
    • 1.6.6 South America Biologics and Biosimilars Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Biologics and Biosimilars Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Biologics and Biosimilars Product and Solutions
    • 2.1.4 Roche Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Amgen
    • 2.2.1 Amgen Details
    • 2.2.2 Amgen Major Business
    • 2.2.3 Amgen Biologics and Biosimilars Product and Solutions
    • 2.2.4 Amgen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Amgen Recent Developments and Future Plans
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie Biologics and Biosimilars Product and Solutions
    • 2.3.4 AbbVie Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 AbbVie Recent Developments and Future Plans
  • 2.4 Sanofi
    • 2.4.1 Sanofi Details
    • 2.4.2 Sanofi Major Business
    • 2.4.3 Sanofi Biologics and Biosimilars Product and Solutions
    • 2.4.4 Sanofi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sanofi Recent Developments and Future Plans
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson Biologics and Biosimilars Product and Solutions
    • 2.5.4 Johnson & Johnson Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Biologics and Biosimilars Product and Solutions
    • 2.6.4 Pfizer Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Pfizer Recent Developments and Future Plans
  • 2.7 Novo Nordisk
    • 2.7.1 Novo Nordisk Details
    • 2.7.2 Novo Nordisk Major Business
    • 2.7.3 Novo Nordisk Biologics and Biosimilars Product and Solutions
    • 2.7.4 Novo Nordisk Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Novo Nordisk Recent Developments and Future Plans
  • 2.8 Eli Lilly
    • 2.8.1 Eli Lilly Details
    • 2.8.2 Eli Lilly Major Business
    • 2.8.3 Eli Lilly Biologics and Biosimilars Product and Solutions
    • 2.8.4 Eli Lilly Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Eli Lilly Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Biologics and Biosimilars Product and Solutions
    • 2.9.4 Novartis Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Merck
    • 2.10.1 Merck Details
    • 2.10.2 Merck Major Business
    • 2.10.3 Merck Biologics and Biosimilars Product and Solutions
    • 2.10.4 Merck Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Merck Recent Developments and Future Plans
  • 2.11 Biogen
    • 2.11.1 Biogen Details
    • 2.11.2 Biogen Major Business
    • 2.11.3 Biogen Biologics and Biosimilars Product and Solutions
    • 2.11.4 Biogen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Biogen Recent Developments and Future Plans
  • 2.12 Celltrion
    • 2.12.1 Celltrion Details
    • 2.12.2 Celltrion Major Business
    • 2.12.3 Celltrion Biologics and Biosimilars Product and Solutions
    • 2.12.4 Celltrion Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Celltrion Recent Developments and Future Plans
  • 2.13 Sobi
    • 2.13.1 Sobi Details
    • 2.13.2 Sobi Major Business
    • 2.13.3 Sobi Biologics and Biosimilars Product and Solutions
    • 2.13.4 Sobi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Sobi Recent Developments and Future Plans
  • 2.14 3SBIO
    • 2.14.1 3SBIO Details
    • 2.14.2 3SBIO Major Business
    • 2.14.3 3SBIO Biologics and Biosimilars Product and Solutions
    • 2.14.4 3SBIO Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 3SBIO Recent Developments and Future Plans
  • 2.15 Changchun High Tech
    • 2.15.1 Changchun High Tech Details
    • 2.15.2 Changchun High Tech Major Business
    • 2.15.3 Changchun High Tech Biologics and Biosimilars Product and Solutions
    • 2.15.4 Changchun High Tech Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Changchun High Tech Recent Developments and Future Plans
  • 2.16 Kanghong Pharma
    • 2.16.1 Kanghong Pharma Details
    • 2.16.2 Kanghong Pharma Major Business
    • 2.16.3 Kanghong Pharma Biologics and Biosimilars Product and Solutions
    • 2.16.4 Kanghong Pharma Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Kanghong Pharma Recent Developments and Future Plans
  • 2.17 Innovent Biologics
    • 2.17.1 Innovent Biologics Details
    • 2.17.2 Innovent Biologics Major Business
    • 2.17.3 Innovent Biologics Biologics and Biosimilars Product and Solutions
    • 2.17.4 Innovent Biologics Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Innovent Biologics Recent Developments and Future Plans
  • 2.18 Gan&Lee
    • 2.18.1 Gan&Lee Details
    • 2.18.2 Gan&Lee Major Business
    • 2.18.3 Gan&Lee Biologics and Biosimilars Product and Solutions
    • 2.18.4 Gan&Lee Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Gan&Lee Recent Developments and Future Plans
  • 2.19 Tonghua Dongbao
    • 2.19.1 Tonghua Dongbao Details
    • 2.19.2 Tonghua Dongbao Major Business
    • 2.19.3 Tonghua Dongbao Biologics and Biosimilars Product and Solutions
    • 2.19.4 Tonghua Dongbao Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Tonghua Dongbao Recent Developments and Future Plans
  • 2.20 United Laboratory
    • 2.20.1 United Laboratory Details
    • 2.20.2 United Laboratory Major Business
    • 2.20.3 United Laboratory Biologics and Biosimilars Product and Solutions
    • 2.20.4 United Laboratory Biologics and Biosimilars Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 United Laboratory Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biologics and Biosimilars Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Biologics and Biosimilars by Company Revenue
    • 3.2.2 Top 3 Biologics and Biosimilars Players Market Share in 2024
    • 3.2.3 Top 6 Biologics and Biosimilars Players Market Share in 2024
  • 3.3 Biologics and Biosimilars Market: Overall Company Footprint Analysis
    • 3.3.1 Biologics and Biosimilars Market: Region Footprint
    • 3.3.2 Biologics and Biosimilars Market: Company Product Type Footprint
    • 3.3.3 Biologics and Biosimilars Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biologics and Biosimilars Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Biologics and Biosimilars Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Biologics and Biosimilars Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Biologics and Biosimilars Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Biologics and Biosimilars Consumption Value by Type (2020-2031)
  • 6.2 North America Biologics and Biosimilars Market Size by Application (2020-2031)
  • 6.3 North America Biologics and Biosimilars Market Size by Country
    • 6.3.1 North America Biologics and Biosimilars Consumption Value by Country (2020-2031)
    • 6.3.2 United States Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Biologics and Biosimilars Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Biologics and Biosimilars Consumption Value by Type (2020-2031)
  • 7.2 Europe Biologics and Biosimilars Consumption Value by Application (2020-2031)
  • 7.3 Europe Biologics and Biosimilars Market Size by Country
    • 7.3.1 Europe Biologics and Biosimilars Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 7.3.3 France Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Biologics and Biosimilars Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biologics and Biosimilars Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Biologics and Biosimilars Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Biologics and Biosimilars Market Size by Region
    • 8.3.1 Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2020-2031)
    • 8.3.2 China Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 8.3.5 India Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Biologics and Biosimilars Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Biologics and Biosimilars Consumption Value by Type (2020-2031)
  • 9.2 South America Biologics and Biosimilars Consumption Value by Application (2020-2031)
  • 9.3 South America Biologics and Biosimilars Market Size by Country
    • 9.3.1 South America Biologics and Biosimilars Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Biologics and Biosimilars Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biologics and Biosimilars Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Biologics and Biosimilars Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Biologics and Biosimilars Market Size by Country
    • 10.3.1 Middle East & Africa Biologics and Biosimilars Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Biologics and Biosimilars Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Biologics and Biosimilars Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Biologics and Biosimilars Market Drivers
  • 11.2 Biologics and Biosimilars Market Restraints
  • 11.3 Biologics and Biosimilars Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biologics and Biosimilars Industry Chain
  • 12.2 Biologics and Biosimilars Upstream Analysis
  • 12.3 Biologics and Biosimilars Midstream Analysis
  • 12.4 Biologics and Biosimilars Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biologics and Biosimilars. Industry analysis & Market Report on Biologics and Biosimilars is a syndicated market report, published as Global Biologics and Biosimilars Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Biologics and Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo